Apple Inc. vs. BioLineRX Ltd
Apple Inc. (AAPL) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| AAPL | BLRX | |
|---|---|---|
| Market Cap | $4.52 trillion | $12.40 million |
| Revenue (TTM) | $466.82 billion | — |
| Net Income (TTM) | $128.93 billion | — |
AAPL leads on 1 of 1 size & scale factors.
Valuation
| AAPL | BLRX | |
|---|---|---|
| P/E Ratio | 36.33 | — |
| Price / Book | 42.08 | — |
| Price / Sales | 9.69 | — |
AAPL and BLRX split the valuation factors evenly.
Profitability
| AAPL | BLRX | |
|---|---|---|
| Net Margin | 27.62% | — |
| Return on Equity | 119.91% | — |
AAPL and BLRX split the profitability factors evenly.
Dividend
| AAPL | BLRX | |
|---|---|---|
| Dividend Yield | 0.34% | — |
| Payout Ratio | 12.39 | — |
AAPL and BLRX split the dividend factors evenly.
Risk & Sentiment
| AAPL | BLRX | |
|---|---|---|
| Short Interest | 0.31% | 12.43% |
AAPL leads on 1 of 1 risk & sentiment factors.
Dig deeper: AAPL overview, AAPL financials, BLRX overview, BLRX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.